chrisvoncsefalvay/vaers-outcomes huggingface dataset:
he developed Acute Disseminated Encephalomyelitis; He is also diagnosed with Transverse myelitis; This is a spontaneous report from a Pfizer sponsored program. A contactable Consumer reported for a male patient (reporter son).  A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history included acute disseminated encephalomyelitis, myelitis transverse. Concomitant medications were not reported. The patient experienced he developed acute disseminated encephalomyelitis; he was also diagnosed with transverse myelitis. her doctor confirmed the vaccine can cause demyelination in adults post vaccination. she has also read some thin like this NORD rare diseases document online. There were no other notable patterns or numerical imbalances between treatment groups for specific categories of serious adverse events (including neurologic, neuro-inflammatory, and thrombotic events) that would suggest a causal relationship to Pfizer-BioNTech COVID-19 Vaccine. they may not have the list of all the possible potential side effect associated with the vaccine. she wants to know if you have any information on minors developing ADEM and transverse myelitis after receiving the vaccine. She was just looking for any data on youth that have had the vaccine with any medical history, but there wasn't any. The outcome of events was unknown.  Information on the lot/batch number has been requested
The child rcv'd the Menveo vaccine on 03-22-21 during day by the evening he had redness and swelling at injection site.  He woke up on 3-23-21 wth facial swelling , called PCP, was advised to go to Urgent care. Urgent care prescribed an EpiPen and steroids. Child  was rcked in PCP office on 3-29-21, completed steroids, doing much better.
p/vax pt had sz,having them ever since,11 sz,febrile sz;high fever;devel asthma in last year;   Annual follow-up received on 09/26/2000 provided no additional data.
I experienced chest pain/pressure, shortness of breath, rapid/irregular heartbeat approximately 5 days after receiving my first dose of the Moderna shot.  I had been exercising outdoors (as I normally do) when it came on.  It subsided some and returned in intensity the following day following a long walk.  It was mostly mild pain and pressure during the week.  However, on 4/24, following exercise, I had pronounced symptoms and acknowledged that I needed to go to the emergency room, as I thought I was having a heart attack.  They admitted me and ran various heart tests and ruled out a heart attack or blood clot.
On 8/28/2022 I had shingles. I went to the emergency room. They went away with treatment, valacyclovir and gabapentin. They gave me a morphine drip while I was in the emergency room for the pain.
fever; Headache; Throat hurting; She is having sore arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administration date 15Dec2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious) with onset Dec2021, outcome "not recovered", described as "fever"; HEADACHE (non-serious) with onset Dec2021, outcome "not recovered", described as "Headache"; OROPHARYNGEAL PAIN (non-serious) with onset Dec2021, outcome "not recovered", described as "Throat hurting"; PAIN IN EXTREMITY (non-serious) with onset Dec2021, outcome "not recovered", described as "She is having sore arm". Therapeutic measures were taken as a result of pyrexia. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from the VAERS database via a journalist. This spontaneous report refers to a patient of unknown age. The patient was vaccinated with lot # (658208/0886U) ZOSTAVAX on 08-JUL-2008. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced herpes zoster. No treatment information was reported. The outcome of herpes zoster is unknown. The relatedness for herpes zoster is unknown for ZOSTAVAX. Additional information is not expected.
Patient received 1st dose COVID vaccine (Pfizer, Lot #EW0185) on 05/26/2021. At the client's 2nd dose appointment for Pfizer on 06/16/2021, she reported that that 15 minutes after receiving her first dose she experienced tingling on the right cheek lasting for about 1 minute.  RN completed a medical consult and received clearance from the county medical team to vaccinate the client with 2nd dose Pfizer and observe for 30 minutes. RN educated about ER precautions and advised client to follow up with her PCP. Client received 2nd COVID vaccine (Pfizer, Lot#EW0187) at 11:15am in the Left arm by EMT Vaccinator.
Severe rash all over body starting about 7 days after administration. The patient saw her physician and the condition resolved.
pt recv vax 4/24/98 & pt devel a rubella like rash (maculopapular);
Elevated blood pressure, elevated pulse, temperature 101.5 resident reports generalized dsicomfort and chest congestion with productive cough
Patient stated she started to develop a rash around possibly 6-8-19 (unsure because she did not pay attention) but noticed more on 6-9-19 that there was a rash (unsure of size) and then notice on 6-10-19 that it was getting larger (about the size of a baseball) around the injection site.  The rash was not hot on 6-10-19 but said it was before then (unsure of when and time frame).  There was a little itching at first (again unsure of time frame) but there is no itching as of 6-10-19.  Tried calling pt on 6-11-19 to follow up but no answer.  Reached patient on 6-13-19 and she stated that she is all better and there is no redness.  Unclear as to when the redness had gone away.  Patient never had a fever, chills, or any other side effects.
Fever; Chills; kind of nauseous like with the name eating; I have been eating things stomach like things stick on stomach; it is swollen under my arm that I got the shot in; headache; Under my arm is lymph node under my arm is very swollen and got bigger; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age received second dose(PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) via an unspecified route of administration on an unspecified date (reported as past Monday) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not provided. The patient received first dose of (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, via an unspecified route of administration on 27Mar2021 as a single dose for COVID-19 immunization. After patient had a second vaccination of Pfizer shot on Monday (as reported). Patient experienced lots of problem like headache, chills, fever and kind of nauseous like with the name eating and she had been eating things stick on stomach and she had swollen under arm that she got the shot in. Under her arm was lymph node swollen and got bigger. Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Patient has history of Vasovagal, didn?t eat prior coming for vaccination. After the client arrived observation, patient verbalize  dizziness, lightheadness, and passed out for 3 seconds.  Noted client shaking, pale. Vital signs was initiated and legs elevated, offered water  and iced pack was applied. Client requested to be laying down on the floor.  Nurses assist client laying down safely.After few minutes client stated feeling better. We extended observation for 30 mins, symptoms are fully resolved. Client left the clinic in stable condition ambulating accompanied @12:45 pm
Headache, Myalgia, Fever, Myalgia,HA,fever,and fatigue Narrative:  Myalgia, HA, fever, and fatigue the day after the 2nd Pfizer COVID vaccination that lasted 2 days causing him to miss work.
pt had temp for 6 days following vax 191.2-102 APAP given; about 3 days p/vax pt was squinting; few days p/that seen staring & would have involuntary movements of rt arm; pt seen by MD who recommended to watch; taken to MD in JUN92;
delayed hypersensitivity reaction occurring approximately 8 days after vaccine administration. large erythematous and pruritic plaque appeared and was self-limiting within several days.
Local Redness and Swelling 70mm in Diameter. Mother denied trying any treatment and appointment made with PCM.
Headache Fever Body aches Started within 12 hours of injection, have lasted 48 hours
Swollen lymph node underarm area; Fluid build up under skin; general swelling on whole left side of torso; Discomfort; Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 13 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Jan2022 (Lot number: ew0161) at the age of 13 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Bee" (unspecified if ongoing); "wasp" (unspecified if ongoing); "vespid allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: ewo178, Location of injection: Arm Left), administration date: 24Jun2021, when the patient was 12 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: 3313OBA, Location of injection: Arm Left), administration date: 14May2021, when the patient was 12 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 10Jan2022, outcome "unknown", described as "Booster"; LYMPHADENOPATHY (non-serious) with onset 11Jan2022, outcome "recovered" (2022), described as "Swollen lymph node underarm area"; FLUID RETENTION (non-serious) with onset 11Jan2022, outcome "recovered" (2022), described as "Fluid build up under skin"; SWELLING (non-serious) with onset 11Jan2022, outcome "recovered" (2022), described as "general swelling on whole left side of torso"; DISCOMFORT (non-serious) with onset 11Jan2022, outcome "recovered" (2022), described as "Discomfort". Therapeutic measures were not taken as a result of lymphadenopathy, fluid retention, swelling, discomfort.  No follow-up attempts are possible. No further information is expected.
PT. COMPLAINED OF BLURRINESS TO HER VISION AND HEARING "BLOCKAGE". SKIN TURNED PALE AND PT STATED SHE DIDN'T FEEL OK. COLD WATER GIVEN AS WELL AS COLD WASH CLOTH. PT REFUSED TO LIE DOWN AND REMAINED IN AN UPRIGHT POSITION. PT WAS OBSERVED FOR 30 MINUTES. AFTER STATING SHE FELT ALOT BETTER PT. WAS D/C'D TO HOME.
Left eye swollen under eye - tender sore to touch morning after shot. Following day swelling same plus extended down cheek, 4th day, still slightly swollen under left eye.
No adverse effect reported; on 8/29/2019, on patient received improperly stored VARlVAX (Lot S005078 & expiration date 2/19/2021 or lot R019237 & expiration date 7/4/2020); This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 29-AUG-2019, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # R019237 and expiry date 04-JUL-2020 or lot # S005078 and expiry date 19-FEB-2021 (the nurse was not sure which lot # was given to the patient); route of administration, injection site and exact dose were not provided) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent. The vaccine was exposed to the temperature between -14 degrees Celsius (C) to -10 C (-9,74 C) during unknown time period. There was no previous temperature excursion. The digital data logger was involved. No adverse effects were reported.
Croup symptoms - 12 hr after mist given with fever.  Steroids given.
17 year old male, (will be 18 on 04/02/2021) - student, volunteered at COVID vaccination event - parents wanted student vaccinated - his father is a cancer patient undergoing stem cell transplant - he needs vaccine to be able to see his father . Parents want pt to proceed with 2nd vaccination (he will be 18 at that time) No adverse events - minimal arm soreness
pt recv vax 1OCT96 & pt exp arthralgia & a low grade fever & devel a maculopapular rash on upper trunk & arms;pt MD suspected the pt devel rubella as a result of vax w/rubella vax;
Within 10 minutes of receiving the vaccination in my right arm I started having painful pins and needle sensations in both hands and wrists. It lasted for about 15 minutes. Then, my arms felt slightly numb to the touch
Initial information received on 21 September 2012 from a consumer. A male patient (age not reported) received a dose of Influenza Vaccine on an unspecified date. An unknown amount of time following vaccination, the patient developed breathing difficulty and was hospitalized. Treatment information and duration of hospitalization was not reported. It was not reported if the patient recovered from his event. Documents held by sender: none.
Menveo dose that was reconstituted using sterile water instead of the  liquid conjugate vaccine; Menveo dose that was reconstituted using sterile water instead of the  liquid conjugate vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 41-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA977A, expiry date 31-MAY-2024) for prophylaxis.   On 15-AUG-2023, the patient received Menveo. On 15-AUG-2023, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: Menveo dose that was reconstituted using sterile water instead of the  liquid conjugate vaccine) and inappropriate dose of vaccine administered (Verbatim: Menveo dose that was reconstituted using sterile water instead of the  liquid conjugate vaccine).     The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 16 Aug 2023 The nurse called to report the administration of a Menveo dose that was reconstituted using sterile water instead of the  liquid conjugate vaccine component. The HCP asked how long the patient had to wait in order to receive a properly reconstituted dose. The patient administration of a Menveo dose that was reconstituted using sterile water instead of the  liquid conjugate vaccine component, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The reporter consented to follow up.
knot under skin at injection site with discoloration to skin, this started happing three days after the shot. left leg and foot swollen,  tightness April 12,2021
Encounter Date:  3/23/2021         Hide copied text  Hover for details 245PM Pifzer first dose Vaccination given.  320 Complaining of not feeling well. States she stayed beyond her 15 minutes as did not feel well. BP 119/80 P86 R 18 Pulse ox 100%. When asked how she was feeling she stated she feels something in her throat. Complains of itching to her back. When examined, found many reddened areas with scratch marks over mid back near bra line. Consulted Dr.  regarding giving Benadryl 25 mg po. She advised to administer. 325 Benadryl 25 mg given po. Denies difficulty swallowing but states not getting air as well. Lung sounds audible but diminished at bases. Unable to auscultate heart sounds per NP due to acoustics.  335 BP 125/85 P 132 R 22. Pulse ox 99%. States more difficulty getting air. Epinephrine 0.3 mg IM given complains of lip feeling tight. 337 Squad arrived and given report. BP 124/67 P138 R 22. Pulse ox 98%. Shivering from Epinephrine administration.  Patient taken to Emergency Department, unable to see records from that facility.
Pt said arm went numb. Today, (day 2) after administering vaccine she can move her arm but still can not drive with left arm.
Pain in bicep down the whole arm and unable to move the arm without the assistance of my other hand. Went to ER due to intense pain and immobility and was diagnosed with Tendonitis.  Had a follow up with my Doctor one week later who diagnosed me with Frozen Shoulder and put me on steroids.  After steroids ran out the pain and immobility are still present and I have received a referral to go to Physical Therapy.  I am also doing acupuncture and massage therapy for pain management.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 73-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Jan2021 at 13:15 as dose 1, single (Lot number: el9263), in left arm, on 11Feb2021 at 14:30 as dose 2, single (Lot number: em9809), in left arm, on 30Sep2021 at 12:15 as dose 3 (booster), single (Lot number: 30145BA), in left arm and on 04Apr2022 at 10:30 as dose 4 (booster), single (Lot number: FK9893) at the age of 72 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Penicillium allergy" (unspecified if ongoing), notes: Penicillium allergy. Concomitant medication(s) included: RALOXIFENE, start date: 01Aug2014; SOLIFENACIN, start date: 01Nov2021. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: two negative tests; Negative, notes: two negative tests. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Treatment start date:23Aug2022, Treatment stop date: 27Aug2022, Indication: Treatment of COVID-19.
stomach nausea; covid; flu; Initial information received on 18-Oct-2023 regarding an unsolicited valid Social Media non-serious case received from a Patient.  This case involves an unknown age and unknown gender patient who experienced stomach nausea, covid and flu after receiving vaccine Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Influenza vaccine produced by unknown manufacturer (lot number, strength, dose, expiry date, formulation not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date the patient developed stomach nausea (nausea), covid (covid-19) and flu (influenza) at the same time (unknown latency) following the administration of Influenza vaccine.  It was reported "I got mine last month just because my doctor had it and covid 2 weeks ago."  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for the events.
developed covid like symptoms a few days later/ tested positive on the 26th; developed covid like symptoms a few days later/tested positive on the 26th; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the vaccine on 18Dec2020 and developed covid like symptoms a few days later in Dec2020 and believed the patient was likely exposed. The patient was tested positive on 26Dec2020. The outcome of the events was unknown.   Information about Lot/Batch number has been requested.; Sender's Comments: The reported covid like symptoms a few days with  tested positive  after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.
Hives started on bottom of my feet that night, the next day i had them on my head and ears. i took benadryl every 4 hours. by the next day i had them all over. i thought my right hand was actually going to burst open it became so swollen. on 9/17 i had an urgent care visit and stated a steroid pack as well.
Few hours, post vax, pt developed swelling, increase in temperature with hyperemia. The arm where the vaccine was given was 3X the size and 1/2 of the arm was swollen. Evaluated at the local ER.
general body aches; right arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (general body aches) and VACCINATION SITE PAIN (right arm was sore) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033F21A, 029L20A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Nov-2021, the patient experienced MYALGIA (general body aches) and VACCINATION SITE PAIN (right arm was sore). In November 2021, MYALGIA (general body aches) had resolved. At the time of the report, VACCINATION SITE PAIN (right arm was sore) outcome was unknown.            The  concomitant medications on use were not provided.  The patient felt general body aches for a day. The patient had no adverse reactions or side effects after her first and second Moderna covid-19 vaccine.   No treatment information was provided.   This case was linked to MOD-2022-535553 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2022: Follow-up information included no new information.
arm is sore; body is achy; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is sore), PAIN (body is achy) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (LEVOXYL) for an unknown indication.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm is sore), PAIN (body is achy) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (arm is sore), PAIN (body is achy) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information does not provided.